Please assess the completion status of the following clinical trial:

Trial Title: Dexmedetomidine Combined With Lidocaine Infusion Affect Inflammation Cytokines

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* American Society of Anesthesiologists (ASA) physical status I and II~* weighted 50 kg-65 kg~* aged 40-65 yr~* elective laparoscopic hysterectomy with general anesthesia~Exclusion Criteria:~* a history of allergy to local anesthetics~* severe respiratory, renal or hepatic disease~* preoperative opioids medication~* psychiatric medical history~* Patients with severe hypotension \[mean arterial pressure (MAP\<60 mmHg)\] or bradycardia \[heart rate (HR) \<40 beats per minute (bpm)\], arrhythmia, or urticaria due to lidocaine and dexmedetomidine infusion during the surgery

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Intravenous saline, dexmedetomidine and lidocaine (Type: EXPERIMENTAL): None
- Intravenous saline, dexmedetomidine, lidocaine and combination (Type: EXPERIMENTAL): None
- Intravenous saline,dexmedetomidine plus lidocaine (Type: EXPERIMENTAL): None
- Intravenous saline, dexmedetomidine combined with lidocaine (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).